Univercells is closing a €3M investment with Takeda
Our customer Univercells partners with Takeda Pharmaceutical Company Limited to produce affordable vaccines for All. Press release: http://www.univercells.com/newsroom/univercells-partners-takeda/
Our customer Univercells partners with Takeda Pharmaceutical Company Limited to produce affordable vaccines for All. Press release: http://www.univercells.com/newsroom/univercells-partners-takeda/
Through a reversible deal, MaSTherCell has been acquired by Orgenesis (a leader in the emerging fields of cellular therapy and re-generative medicine for the treatment of Type 1 Diabetes) in March 2015. MaSTherCell will be responsible for the development and the commercialization of Orgenesis’ product and will also maintain his CDMO core business activity in[…]